Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5α and 22

被引:0
|
作者
Anna Kajaste-Rudnitski
Cinzia Pultrone
Flavia Marzetta
Silvia Ghezzi
Tiziana Coradin
Elisa Vicenzi
机构
[1] San Raffaele Scientific Institute,Viral Pathogens and Biosafety Unit, Division of Immunology, Transplantation and Infectious Diseases
[2] P2/P3 Laboratories,undefined
[3] DIBIT,undefined
来源
Amino Acids | 2010年 / 39卷
关键词
Retroviral infection; Host restriction factors; TRIM family proteins;
D O I
暂无
中图分类号
学科分类号
摘要
Viral tropism, replication, and pathogenesis are determined by multiple interactions between the pathogen and the host. In the case of retroviruses, and in particular, the human immunodeficiency virus, the specific interaction of the envelope protein with the host receptors and co-receptors is essential to gain entry in the cells. After entry, the success of retroviruses to complete their life cycle depends on a complex interplay between the virus and host proteins. Indeed, the cell environment is endowed with a number of factors that actively block distinct stage(s) in the microbial life cycle. Among these restriction factors, Tripartite Motif-5α (TRIM5α) has been extensively studied; however, other TRIM family members have been demonstrated to be anti-retroviral effector proteins. This article reviews, in particular, the current knowledge on the anti-retroviral effects of TRIM5α and TRIM22.
引用
收藏
页码:1 / 9
页数:8
相关论文
共 50 条
  • [41] Tripartite motif-containing protein 11 (TRIM11): a novel weapon against Alzheimer's disease
    Fu, Yichu
    Zhang, Bi
    Liu, Jianfeng
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [42] TRIpartite Motif 21 (TRIM21) Differentially Regulates the Stability of Interferon Regulatory Factor 5 (IRF5) Isoforms
    Lazzari, Elisa
    Korczeniewska, Justyna
    Gabhann, Joan Ni
    Smith, Siobhan
    Barnes, Betsy J.
    Jefferies, Caroline A.
    PLOS ONE, 2014, 9 (08):
  • [43] Retroviral restriction factors Fv1 and TRIM5α act independently and can compete for incoming virus before reverse transcription
    Passerini, LD
    Keckesova, Z
    Towers, GJ
    JOURNAL OF VIROLOGY, 2006, 80 (05) : 2100 - 2105
  • [44] Tripartite motif-containing protein 11 (TRIM11): a novel weapon against Alzheimer’s disease
    Yichu Fu
    Bi Zhang
    Jianfeng Liu
    Signal Transduction and Targeted Therapy, 9
  • [45] Interleukin 27, Similar to Interferons, Modulates Gene Expression of Tripartite Motif (TRIM) Family Members and Interferes with Mayaro Virus Replication in Human Macrophages
    Hernandez-Sarmiento, Lady Johana
    Tamayo-Molina, Y. S.
    Valdes-Lopez, Juan Felipe
    Urcuqui-Inchima, Silvio
    VIRUSES-BASEL, 2024, 16 (06):
  • [46] Interleukin-22 facilitates the interferon-λ-mediated production of tripartite motif protein 25 to inhibit replication of duck viral hepatitis A virus type 1
    Hao An
    Yumei Liu
    Ming Shu
    Junhao Chen
    Veterinary Research, 54
  • [47] An Invariant Surface Patch on the TRIM5α PRYSPRY Domain Is Required for Retroviral Restriction but Dispensable for Capsid Binding
    Sebastian, Sarah
    Gruetter, Christian
    de Castillia, Caterina Strambio
    Pertel, Thomas
    Olivari, Silvia
    Gruetter, Markus G.
    Luban, Jeremy
    JOURNAL OF VIROLOGY, 2009, 83 (07) : 3365 - 3373
  • [48] Positive selection of primate TRIM5α identifies a critical species-specific retroviral restriction domain
    Sawyer, SL
    Wu, LI
    Emerman, M
    Malik, HS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (08) : 2832 - 2837
  • [49] Interleukin-22 facilitates the interferon-λ-mediated production of tripartite motif protein 25 to inhibit replication of duck viral hepatitis A virus type 1
    An, Hao
    Liu, Yumei
    Shu, Ming
    Chen, Junhao
    VETERINARY RESEARCH, 2023, 54 (01) : 53
  • [50] The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5α
    Javanbakht, H
    Diaz-Griffero, F
    Stremlau, M
    Si, ZH
    Sodroski, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (29) : 26933 - 26940